Skip to main content
OpenTrials
Completed

NCT Number: NCT00415402

Effect of Vitamin D Supplementation on Health of Low Birth Weight Infants

The purpose of this study is to determine whether a weekly supplement of vitamin D to low birth weight term infants will reduce their mortality and hospital admissions and improve their immunity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

24 hour–2 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute of Home Economics, Delhi University

New Delhi, 110016, India

About this study

We are conducting a randomised controlled trial of weekly oral vitamin D supplements to low birth weight (< 2.5 kg) term infants born in a large government hospital catering to a low-middle income population in Delhi. Mothers and infants are recruited at delivery and given weekly vitamin D supplements or placebo until 6 months of age. Data on infant morbidity, sun exposure and diet, with particular emphasis on breast milk and other milk intake, is collected by fieldworkers visiting the homes each fortnight. Mothers are encouraged to bring their infants to the hospital in case of any illness and at these visits the infant is seen by the project doctor who treats the infant and records additional morbidity data. At 6 months blood samples are being collected from a 20% random subsample of infants for measurement of 25OHD and indicators of immune activation. The primary outcome is mortality or incidence of any illness requiring admission to hospital.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Born at term, as determined from last menstrual period
  • Weighing < 2.5 kg
  • Resident within 12 km of the hospital and expected to continue living in the area for the following 6 months
  • With no severe congenital abnormalities
  • No morbidity severe enough to be expected to result in death before 7 days due to severe respiratory distress, shock, pulmonary sepsis, etc.
  • Parental informed consent

Treatment and study plan

Vitamin D3

Drug

Primary outcomes

  1. Mortality

    Time frame: weekly

  2. Incidence of disease requiring hospitalization

  3. Morbidity and hospitalization

    Time frame: weekly

Secondary outcomes

  1. Incidence of infectious disease not requiring hospitalization

  2. Severe morbidity requiring hospitalization

Sponsors and collaborators

Lead sponsor

Delhi University

Other

Collaborators

  • London School of Hygiene and Tropical Medicine
  • Sitaram Bhartia Institute of Science and Research

Registry information

Official study title

Randomised Controlled Trial to Evaluate the Preventive Effect on Mortality and Serious Morbidity/ Hospitalisations of Daily Vitamin D Supplements in Small for Gestational Age Term Infants

Acronym: DIVIDS

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Dec 22, 2006
Registry last updated
Aug 22, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.